Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.24.2.u1
Segment Information (Tables)
6 Months Ended
Jun. 29, 2024
Segment Reporting [Abstract]  
Schedule of Segment Information
The following tables present our segment information for the 13 and 26 weeks ended June 29, 2024 and July 1, 2023 (in $000’s):
Thirteen Weeks Ended Twenty-Six Weeks Ended
June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023
Revenues
Biotechnology $ —  $ —  $ —  $ — 
Fintech 2,169  —  2,169  — 
Discontinued operations —  —  —  3,795 
Total Revenues $ 2,169  $ —  $ 2,169  $ 3,795 
Gross profit
Biotechnology $ —  $ —  $ —  $ — 
Fintech 1,098  —  1,098  — 
Discontinued operations —  —  —  (197)
Total Gross profit $ 1,098  $ —  $ 1,098  $ (197)
Operating income (loss)
Biotechnology $ (3,177) $ (1,060) $ (4,983) $ (2,159)
Fintech 261  —  261  — 
Discontinued operations —  —  —  14,159 
Total Operating income (loss) $ (2,916) $ (1,060) $ (4,722) $ 12,000 
Depreciation and amortization
Biotechnology $ —  $ 362  $ —  $ 726 
Fintech 179  —  179  — 
Discontinued operations —  —  —  96 
Total Depreciation and amortization $ 179  $ 362  $ 179  $ 822 
Interest (income) expense, net
Biotechnology $ (161) $ (365) $ 91  $ (840)
Fintech 157  —  157  — 
Discontinued operations —  —  —  181 
Total Interest expense, net $ (4) $ (365) $ 248  $ (659)
Net income (loss) before income taxes
Biotechnology $ (3,112) $ 62  $ (5,331) $ (827)
Fintech 850  —  850  — 
Discontinued operations —  —  13,976 
Total Net income before income taxes $ (2,262) $ 63  $ (4,481) $ 13,149